These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 28357822)

  • 81. Effects of hyperbaric oxygen on rat embryos.
    Sapunar D; Saraga-Babić M; Peruzović M; Marusić M
    Biol Neonate; 1993; 63(6):360-9. PubMed ID: 8373909
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Development and in vitro evaluation of a flow-adjustable elastic drug infusion pump.
    Choi SW; Kang SM; Kim HY; Nam KW
    Proc Inst Mech Eng H; 2011 Nov; 225(11):1070-7. PubMed ID: 22292205
    [TBL] [Abstract][Full Text] [Related]  

  • 83. In-use Stability of Ceftaroline Fosamil in Elastomeric Home Infusion Systems and MINI-BAG Plus Containers.
    Bhattacharya S; Parekh S; Dedhiya M
    Int J Pharm Compd; 2015; 19(5):432-6. PubMed ID: 26775451
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Stability of ceftazidime (with arginine) in an elastomeric infusion device.
    Bednar DA; Klutman NE; Henry DW; Fox JL; Strayer AH
    Am J Health Syst Pharm; 1995 Sep; 52(17):1912-4. PubMed ID: 8528856
    [No Abstract]   [Full Text] [Related]  

  • 85. Effects of hyperbaric oxygen on blood glucose levels in patients with diabetes mellitus, stroke or traumatic brain injury and healthy volunteers: a prospective, crossover, controlled trial.
    Peleg RK; Fishlev G; Bechor Y; Bergan J; Friedman M; Koren S; Tirosh A; Efrati S
    Diving Hyperb Med; 2013 Dec; 43(4):218-21. PubMed ID: 24510327
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Performance of selected flow-restricting infusion devices.
    Capes DF; Asiimwe D
    Am J Health Syst Pharm; 1998 Feb; 55(4):351-9. PubMed ID: 9504194
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Innovative ambulatory drug delivery system using an electrolytic hydrogel infusion pump.
    Kim HC; Bae YH; Kim SW
    IEEE Trans Biomed Eng; 1999 Jun; 46(6):663-9. PubMed ID: 10356873
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Electric pumps and hyperbaric treatment.
    Lévecque JP; Vincenti-Rouquette I; Rousseau JM
    Anesthesiology; 2000 Aug; 93(2):586. PubMed ID: 10910519
    [No Abstract]   [Full Text] [Related]  

  • 89. Retrospective analysis of failures of ambulatory elastomeric pumps containing 5-FU in a hospital pharmacy unit.
    Chefchaouni AC; Ouedraogo JM; Bechar H; Belahcen MJ; Rahali Y
    J Oncol Pharm Pract; 2023 Jan; 29(1):125-129. PubMed ID: 34783287
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Drug stability and pyridine generation in ceftazidime injection stored in an elastomeric infusion device.
    Stendal TL; Klem W; Tønnesen HH; Kjønniksen I
    Am J Health Syst Pharm; 1998 Apr; 55(7):683-5. PubMed ID: 9558424
    [No Abstract]   [Full Text] [Related]  

  • 91. Effects of hyperbaric pressure on a deep-sea archaebacterium in stainless steel and glass-lined vessels.
    Nelson CM; Schuppenhauer MR; Clark DS
    Appl Environ Microbiol; 1991 Dec; 57(12):3576-80. PubMed ID: 16348606
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Impact of air temperature and drug concentration on liquid emission from elastomeric pumps.
    Abe T; Matsuzaka K; Nakayama T; Otsuka M; Sagara A; Sato F; Yumoto T
    J Pharm Health Care Sci; 2021 Jan; 7(1):1. PubMed ID: 33397508
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Stability of 14 drugs in the latex reservoir of an elastomeric infusion device.
    Allen LV; Stiles ML; Prince SJ; Smeeding J
    Am J Health Syst Pharm; 1996 Nov; 53(22):2740-3. PubMed ID: 8931819
    [No Abstract]   [Full Text] [Related]  

  • 94. Design Guidelines for Thermally Driven Micropumps of Different Architectures Based on Target Applications via Kinetic Modeling and Simulations.
    López Quesada G; Tatsios G; Valougeorgis D; Rojas-Cárdenas M; Baldas L; Barrot C; Colin S
    Micromachines (Basel); 2019 Apr; 10(4):. PubMed ID: 31013999
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Characteristics of the Pharmaseal continuous flushing device.
    McKinney MS; Orr IA
    Anaesthesia; 1989 Mar; 44(3):242-4. PubMed ID: 2705612
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Safe disconnection of 5-fluorouracil elastomeric pumps: The benefit of a closed-system-transfer device designed for cytotoxic drug administration/perfusion.
    Raphaëlle P; Elodie P; Nathalie J; Odile A; Paul S; Isabelle M; Hélène L
    J Vasc Access; 2023 Jul; 24(4):653-659. PubMed ID: 34538108
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Peripheral blockade with elastomeric pumps. Our experience.
    Santeularia T; Castillo C; Melo M; Català E
    Rev Esp Anestesiol Reanim; 2016 Nov; 63(9):549-550. PubMed ID: 27349865
    [No Abstract]   [Full Text] [Related]  

  • 98. Effect of environmental conditions on performance of elastomeric pumps.
    Salman D; Barton S; Nabhani-Gebara S
    Am J Health Syst Pharm; 2013 Jul; 70(13):1100. PubMed ID: 23784153
    [No Abstract]   [Full Text] [Related]  

  • 99. Effect of environmental conditions on performance of elastomeric pumps--author's reply.
    Wang J
    Am J Health Syst Pharm; 2013 Jul; 70(13):1100-1. PubMed ID: 23784154
    [No Abstract]   [Full Text] [Related]  

  • 100. Elastomeric pumps: How cautious should we be?
    Ray S; Agrawal B; Dias R; Dave N
    Indian J Anaesth; 2018 Jul; 62(7):558-559. PubMed ID: 30078861
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.